Pub Date : 2023-03-24DOI: 10.1515/labmed-2022-0167
J. Weikert, Angelina Mehrländer, R. Baber
Abstract Objectives Biobanked samples are becoming increasingly important for research outcomes. Most of the biobanking processes (from preparation to storage) are affected by temperature in a time-dependent manner and have a high impact on sample quality. We aimed to validate time and temperature sensitive processes such as sample preparation, transport, sorting, and storage, which have a high impact on sample quality. Methods Temperature was measured using internal or external temperature data loggers. We analysed the temperature and present real data from our sample transport on dry ice and with the CryoPod, from our ultra-low temperature freezers (UTFs) of different manufacturers and cryostores. We also tested sample sorting on dry ice and in a cryogenic workbench. Results In the UTFs, we identified temperature zones with a temperature difference from 4.7 °C up to 20.8 °C across the whole UTF. For sample transport within approximately 30 min we observed temperatures of −80.2 °C ± 4.0 °C and −173.9 °C ± 16.9 °C for dry ice boxes and the CryoPod, respectively. Sorting on dry ice was best in a polystyrene box half-filled with dry ice pellets, although the temperature increased by 7.5 °C within the first 5 min, whereas the temperature in the cryogenic workbench remained stable below −100 °C for hours. Conclusions Time and temperature play a crucial role in the entire biobanking process, with sometimes immense temperature fluctuations in some equipment. We recommend the validation or verification of all equipment and processes used to avoid pre-analytical errors in accordance with DIN EN ISO 20387.
摘要目的生物样本对研究成果越来越重要。大多数生物库过程(从制备到储存)都受温度的影响，并且对样品质量有很大的影响。我们旨在验证时间和温度敏感的过程，如样品制备、运输、分拣和储存，这些过程对样品质量有很大影响。方法采用内、外温度记录仪测温。我们分析了样品在干冰和CryoPod上运输的温度和真实数据，这些数据来自不同制造商的超低温冷冻机(utf)和冷冻库。我们还在干冰和低温工作台上测试了样品分选。在UTF中，我们确定了整个UTF的温差从4.7°C到20.8°C的温度区域。对于大约30分钟的样品运输，我们观察到干冰盒和CryoPod的温度分别为- 80.2°C±4.0°C和- 173.9°C±16.9°C。在半填充干冰球的聚苯乙烯箱中，在干冰上分选效果最好，尽管在前5分钟内温度升高了7.5℃，而在低温工作台上的温度在- 100℃以下保持稳定数小时。结论时间和温度在整个生物库过程中起着至关重要的作用，有时某些设备的温度波动很大。我们建议根据DIN EN ISO 20387对所有设备和工艺进行确认或验证，以避免分析前误差。
{"title":"Keep cool! Observed temperature variations at different process stages of the biobanking workflow – examples from the Leipzig medical biobank","authors":"J. Weikert, Angelina Mehrländer, R. Baber","doi":"10.1515/labmed-2022-0167","DOIUrl":"https://doi.org/10.1515/labmed-2022-0167","url":null,"abstract":"Abstract Objectives Biobanked samples are becoming increasingly important for research outcomes. Most of the biobanking processes (from preparation to storage) are affected by temperature in a time-dependent manner and have a high impact on sample quality. We aimed to validate time and temperature sensitive processes such as sample preparation, transport, sorting, and storage, which have a high impact on sample quality. Methods Temperature was measured using internal or external temperature data loggers. We analysed the temperature and present real data from our sample transport on dry ice and with the CryoPod, from our ultra-low temperature freezers (UTFs) of different manufacturers and cryostores. We also tested sample sorting on dry ice and in a cryogenic workbench. Results In the UTFs, we identified temperature zones with a temperature difference from 4.7 °C up to 20.8 °C across the whole UTF. For sample transport within approximately 30 min we observed temperatures of −80.2 °C ± 4.0 °C and −173.9 °C ± 16.9 °C for dry ice boxes and the CryoPod, respectively. Sorting on dry ice was best in a polystyrene box half-filled with dry ice pellets, although the temperature increased by 7.5 °C within the first 5 min, whereas the temperature in the cryogenic workbench remained stable below −100 °C for hours. Conclusions Time and temperature play a crucial role in the entire biobanking process, with sometimes immense temperature fluctuations in some equipment. We recommend the validation or verification of all equipment and processes used to avoid pre-analytical errors in accordance with DIN EN ISO 20387.","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"69 - 80"},"PeriodicalIF":1.2,"publicationDate":"2023-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44933070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-24DOI: 10.1515/labmed-2022-0155
Sixuan Wang, Xiaoxi Wang, Ling-bin Shu
Abstract Objectives Routine blood examination, one of the most commonly performed tests in clinical laboratories, directly reflects the overall state of the body such as inflammation, anemia, and thrombocytopenia. The accuracy of these indicators by tests may be perturbed by various factors including anticoagulants, antibodies, and temperatures. Pseudoleukopenia caused by leukoagglutination was rarely described in the literature. Case presentation We report a rare and unusual pseudo-leukopenia case of a 75-year-old female with a stroke. Blood samples from the patient were collected using different anticoagulants and determined the hematologic parameters and blood smears. We observed the extent of leukocyte aggregation at different anticoagulants or temperatures. The intensity of leukoagglutination was attenuated after incubating at 37 °C for 30 min. After anti-infection treatment and symptomatic treatment, the leukoagglutination of the patient gradually weakened. Conclusions We have found the reason for the pseudo-leukopenia and the leukocyte aggregation phenomenon may vary with disease progression.
{"title":"A case report of pseudoleukopenia: playing hide-and-seek","authors":"Sixuan Wang, Xiaoxi Wang, Ling-bin Shu","doi":"10.1515/labmed-2022-0155","DOIUrl":"https://doi.org/10.1515/labmed-2022-0155","url":null,"abstract":"Abstract Objectives Routine blood examination, one of the most commonly performed tests in clinical laboratories, directly reflects the overall state of the body such as inflammation, anemia, and thrombocytopenia. The accuracy of these indicators by tests may be perturbed by various factors including anticoagulants, antibodies, and temperatures. Pseudoleukopenia caused by leukoagglutination was rarely described in the literature. Case presentation We report a rare and unusual pseudo-leukopenia case of a 75-year-old female with a stroke. Blood samples from the patient were collected using different anticoagulants and determined the hematologic parameters and blood smears. We observed the extent of leukocyte aggregation at different anticoagulants or temperatures. The intensity of leukoagglutination was attenuated after incubating at 37 °C for 30 min. After anti-infection treatment and symptomatic treatment, the leukoagglutination of the patient gradually weakened. Conclusions We have found the reason for the pseudo-leukopenia and the leukocyte aggregation phenomenon may vary with disease progression.","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"81 - 85"},"PeriodicalIF":1.2,"publicationDate":"2023-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44054719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-22DOI: 10.1515/labmed-2023-0025
Ralf Junker, P. Luppa
{"title":"Congress report: 5th Munich POCT Symposium, September 27–29, 2022, Klinikum rechts der Isar der TU München","authors":"Ralf Junker, P. Luppa","doi":"10.1515/labmed-2023-0025","DOIUrl":"https://doi.org/10.1515/labmed-2023-0025","url":null,"abstract":"","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"87 - 95"},"PeriodicalIF":1.2,"publicationDate":"2023-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42672343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-22DOI: 10.1515/labmed-2022-0147
R. Haeckel, T. Ammer, W. Wosniok, Alexander Krebs, A. Torge, Mustafa Özçürümez, Alexander Bertram
Abstract Objectives Reference intervals of total cholesterol concentrations in plasma and of their fractions low-density lipoprotein (LDL)-, high-density lipoprotein (HDL)-and non-HDL concentrations are seldom studied with respect to the relevance of age and sex. Therefore, the effect of age and sex on the reference intervals was reinvestigated with 2 indirect procedures. Methods As an indirect approach, the truncated minimum chi-square method was applied. All analyses were performed by computer programs available. The script published on the homepage of the German Society of Clinical Chemistry and Laboratory Medicine (DGKL) allows to derive a continuous age dependency of reference intervals together with their confidence and equivalence limits. The results of this approach were compared with those obtained by an indirect method developed more recently, the refineR algorithm. Results In the present study, the upper reference limits of total cholesterol varied from 5.1 to 7.8 mmol/L (197–302 mg/dL) depending on various biological variables (as age, sex, inpatients versus outpatients). These upper limits increased with age. Differences between sexes can be neglected except for the age above 80 years. The pattern of reference limits of LDL cholesterol and non-HDL cholesterol paralleled those of total cholesterol. The reference limits of HDL cholesterol were higher in women than in men but were independent of age. Conclusions Reference limits for the concentrations of total cholesterol and their fractions LDL-, HDL-and non-HDL concentrations should be stratified for age and sex.
{"title":"Age-and sex-specific reference intervals of total cholesterol, LDL cholesterol, HDL cholesterol and non-HDL cholesterol. Comparison of two algorithms for the indirect estimation of reference intervals","authors":"R. Haeckel, T. Ammer, W. Wosniok, Alexander Krebs, A. Torge, Mustafa Özçürümez, Alexander Bertram","doi":"10.1515/labmed-2022-0147","DOIUrl":"https://doi.org/10.1515/labmed-2022-0147","url":null,"abstract":"Abstract Objectives Reference intervals of total cholesterol concentrations in plasma and of their fractions low-density lipoprotein (LDL)-, high-density lipoprotein (HDL)-and non-HDL concentrations are seldom studied with respect to the relevance of age and sex. Therefore, the effect of age and sex on the reference intervals was reinvestigated with 2 indirect procedures. Methods As an indirect approach, the truncated minimum chi-square method was applied. All analyses were performed by computer programs available. The script published on the homepage of the German Society of Clinical Chemistry and Laboratory Medicine (DGKL) allows to derive a continuous age dependency of reference intervals together with their confidence and equivalence limits. The results of this approach were compared with those obtained by an indirect method developed more recently, the refineR algorithm. Results In the present study, the upper reference limits of total cholesterol varied from 5.1 to 7.8 mmol/L (197–302 mg/dL) depending on various biological variables (as age, sex, inpatients versus outpatients). These upper limits increased with age. Differences between sexes can be neglected except for the age above 80 years. The pattern of reference limits of LDL cholesterol and non-HDL cholesterol paralleled those of total cholesterol. The reference limits of HDL cholesterol were higher in women than in men but were independent of age. Conclusions Reference limits for the concentrations of total cholesterol and their fractions LDL-, HDL-and non-HDL concentrations should be stratified for age and sex.","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"55 - 62"},"PeriodicalIF":1.2,"publicationDate":"2023-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66984102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-06DOI: 10.1515/labmed-2022-0154
Jonathan A. Saenger, J. Atamaniuk, M. Gaggl, Johannes Asenbaum, Florian A. Huber, A. Grieb, M. Födinger
Abstract Objectives Automated sample delivery and laboratory acceptance systems (PTAS) may influence the hemolysis rate of blood samples due to g-forces, abrupt acceleration, and rapid deceleration. However, quantitative data regarding the rate of hemolysis in PTAS is limited. To fill this void, the effect of a pneumatic tube in combination with an acceptance system (PTAS) on the hemolysis rate was investigated in this study. Methods Lithium heparin plasma tubes were transported from different clinical departments to the hospital’s laboratory (a) by employees or (b) with an automated PTAS and analyzed for the presence of hemolysis based on a hemolysis index (HI) of >25. Hemolysis indices of 68.513 samples were retrieved from the laboratory information system before and after installation of the PTAS and were subjected to statistical analysis. Results A total of 32.614 samples were transported by employees, of which 3.815 samples (11.70%) were hemolytic, and 9.441 out of 35.899 samples delivered by PTAS (26.30%) were hemolytic. After the implementation of the PTAS, hemolysis rates increased in all departments. Conclusions Automated PTAS are associated with increased hemolysis rates. This has implications for routine patient management and should be considered for the transportation of samples used for the determination of hemolysis-sensitive laboratory parameters.
{"title":"Increased hemolysis rate in plasma tubes after implementation of a fully automated sample delivery and acceptance system","authors":"Jonathan A. Saenger, J. Atamaniuk, M. Gaggl, Johannes Asenbaum, Florian A. Huber, A. Grieb, M. Födinger","doi":"10.1515/labmed-2022-0154","DOIUrl":"https://doi.org/10.1515/labmed-2022-0154","url":null,"abstract":"Abstract Objectives Automated sample delivery and laboratory acceptance systems (PTAS) may influence the hemolysis rate of blood samples due to g-forces, abrupt acceleration, and rapid deceleration. However, quantitative data regarding the rate of hemolysis in PTAS is limited. To fill this void, the effect of a pneumatic tube in combination with an acceptance system (PTAS) on the hemolysis rate was investigated in this study. Methods Lithium heparin plasma tubes were transported from different clinical departments to the hospital’s laboratory (a) by employees or (b) with an automated PTAS and analyzed for the presence of hemolysis based on a hemolysis index (HI) of >25. Hemolysis indices of 68.513 samples were retrieved from the laboratory information system before and after installation of the PTAS and were subjected to statistical analysis. Results A total of 32.614 samples were transported by employees, of which 3.815 samples (11.70%) were hemolytic, and 9.441 out of 35.899 samples delivered by PTAS (26.30%) were hemolytic. After the implementation of the PTAS, hemolysis rates increased in all departments. Conclusions Automated PTAS are associated with increased hemolysis rates. This has implications for routine patient management and should be considered for the transportation of samples used for the determination of hemolysis-sensitive laboratory parameters.","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"63 - 68"},"PeriodicalIF":1.2,"publicationDate":"2023-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46844271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-01DOI: 10.1515/labmed-2022-0162
Sebastian Gibb, Thomas Berg, A. Herber, B. Isermann, T. Kaiser
Abstract Objectives The shortage of grafts for liver transplantation requires risk stratification and adequate allocation rules. This study aims to improve the model of end-stage liver disease (MELD) score for 90-day mortality prediction with the help of different machine-learning algorithms. Methods We retrospectively analyzed the clinical and laboratory data of 654 patients who were recruited during the evaluation process for liver transplantation at University Hospital Leipzig. After comparing 13 different machine-learning algorithms in a nested cross-validation setting and selecting the best performing one, we built a new model to predict 90-day mortality in patients with end-stage liver disease. Results Penalized regression algorithms yielded the highest prediction performance in our machine-learning algorithm benchmark. In favor of a simpler model, we chose the least absolute shrinkage and selection operator (lasso) regression. Beside the classical MELD international normalized ratio (INR) and bilirubin, the lasso regression selected cystatin C over creatinine, as well as IL-6, total protein, and cholinesterase. The new model offers improved discrimination and calibration over MELD and MELD with sodium (MELD-Na), MELD 3.0, or the MELD-Plus7 risk score. Conclusions We provide a new machine-learning-based model of end-stage liver disease that incorporates synthesis and inflammatory markers and may improve the classical MELD score for 90-day survival prediction.
{"title":"A new machine-learning-based prediction of survival in patients with end-stage liver disease","authors":"Sebastian Gibb, Thomas Berg, A. Herber, B. Isermann, T. Kaiser","doi":"10.1515/labmed-2022-0162","DOIUrl":"https://doi.org/10.1515/labmed-2022-0162","url":null,"abstract":"Abstract Objectives The shortage of grafts for liver transplantation requires risk stratification and adequate allocation rules. This study aims to improve the model of end-stage liver disease (MELD) score for 90-day mortality prediction with the help of different machine-learning algorithms. Methods We retrospectively analyzed the clinical and laboratory data of 654 patients who were recruited during the evaluation process for liver transplantation at University Hospital Leipzig. After comparing 13 different machine-learning algorithms in a nested cross-validation setting and selecting the best performing one, we built a new model to predict 90-day mortality in patients with end-stage liver disease. Results Penalized regression algorithms yielded the highest prediction performance in our machine-learning algorithm benchmark. In favor of a simpler model, we chose the least absolute shrinkage and selection operator (lasso) regression. Beside the classical MELD international normalized ratio (INR) and bilirubin, the lasso regression selected cystatin C over creatinine, as well as IL-6, total protein, and cholinesterase. The new model offers improved discrimination and calibration over MELD and MELD with sodium (MELD-Na), MELD 3.0, or the MELD-Plus7 risk score. Conclusions We provide a new machine-learning-based model of end-stage liver disease that incorporates synthesis and inflammatory markers and may improve the classical MELD score for 90-day survival prediction.","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"13 - 21"},"PeriodicalIF":1.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41686192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-01DOI: 10.1515/labmed-2022-0082
Kenfen Li, Yanping Zhang, Yunfeng Wang, Xin Guo, Xianhui Dai, L. Song
Abstract Objectives Lung cancer is a common malignant tumour of the lung and the leading cause of cancer mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for 80–85% of lung cancers, and 40% of NSCLCs have spread beyond the lungs by the time they are diagnosed. The long noncoding RNA (lncRNA) prostate androgen-regulated transcript 1 (PART-1) has been reported to promote the development of several cancers. Methods In the current study, we investigated the role of PART-1 in the proliferation, invasion, and migration of NSCLC. Results The expression levels of the PART-1 gene were higher in NSCLC cell lines, including A549, H1229, H1650, H1975, and PC9, than in human bronchial epithelia (HBE) cell lines. Knocking down PART-1 inhibited the proliferation, invasion, and migration of A549 cells and decreased tumour proliferation in nude mice. We confirmed that PART-1 targeted miR-204-3p directly and that miR-204-3p targeted insulin-like growth factor binding protein 2 (IGFBP-2) directly. Furthermore, we discovered that PART-1 impacts NSCLC progression by regulating the miR-204-3p-targeted IGFBP-2 pathway. Conclusions The lncRNA PART-1 might be a target for treating NSCLC and an early marker in the diagnosis of early lung cancer.
{"title":"The lncRNA prostate androgen-regulated transcript 1 (PART-1) promotes non-small cell lung cancer progression by regulating the miR-204-3p/IGFBP-2 pathway","authors":"Kenfen Li, Yanping Zhang, Yunfeng Wang, Xin Guo, Xianhui Dai, L. Song","doi":"10.1515/labmed-2022-0082","DOIUrl":"https://doi.org/10.1515/labmed-2022-0082","url":null,"abstract":"Abstract Objectives Lung cancer is a common malignant tumour of the lung and the leading cause of cancer mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for 80–85% of lung cancers, and 40% of NSCLCs have spread beyond the lungs by the time they are diagnosed. The long noncoding RNA (lncRNA) prostate androgen-regulated transcript 1 (PART-1) has been reported to promote the development of several cancers. Methods In the current study, we investigated the role of PART-1 in the proliferation, invasion, and migration of NSCLC. Results The expression levels of the PART-1 gene were higher in NSCLC cell lines, including A549, H1229, H1650, H1975, and PC9, than in human bronchial epithelia (HBE) cell lines. Knocking down PART-1 inhibited the proliferation, invasion, and migration of A549 cells and decreased tumour proliferation in nude mice. We confirmed that PART-1 targeted miR-204-3p directly and that miR-204-3p targeted insulin-like growth factor binding protein 2 (IGFBP-2) directly. Furthermore, we discovered that PART-1 impacts NSCLC progression by regulating the miR-204-3p-targeted IGFBP-2 pathway. Conclusions The lncRNA PART-1 might be a target for treating NSCLC and an early marker in the diagnosis of early lung cancer.","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"31 - 40"},"PeriodicalIF":1.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46976919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-01DOI: 10.1515/labmed-2022-0081
R. Obeid, Christoph Möller, J. Geisel
Abstract Objectives Concentrations of pyridoxal 5′-phosphate (PLP) in serum and whole blood are routinely measured. The suitability of these markers in capturing vitamin B6 insufficiency is not well studied. Methods In 212 subjects, concentrations of PLP and thiamine pyrophosphate (TPP) were simultaneously measured in EDTA-whole blood using Chromsystems® (52052) method on HPLC devices. The whole blood PLP concentrations were compared to serum PLP concentrations measured using reagents from Immundiagnostik® (KC 2100). The whole blood TPP concentrations measured with the Chromsystems® (52052) were compared to those measured by the Chromsystems® (35000) method. Concentrations of homocysteine (tHcy) and cystathionine (Cys) were measured and used to judge the PLP methods. Results Serum PLP concentrations were on average 41% lower than whole blood PLP [mean (SD)=55.4 (83.0) vs. 131 (217) nmol/L]. Serum and whole blood PLP showed a strong correlation [Pearson correlation coefficient=0.724, p<0.001, n=204]. Eighty-five samples showed discrepant results for PLP status (serum PLP ≤30 nmol/L, but whole blood PLP >51 nmol/L) while 102 samples showed coherent results (reference group). The discrepancy group showed higher odds ratio for elevated tHcy >12.0 μmol/L compared to the reference group [OR (95% confidence intervals, CI)=2.1 (1.2–4.0)]. The OR (95% CI) of elevated Cys >300 nmol/L was 1.9 (1.0–3.5) in the discrepancy group compared to the reference group. TPP concentrations were 6% lower when using the Chromsystems®, 52052 compared to levels measured with Chromsystems®, 35000. Conclusions Serum and whole blood PLP concentrations disagree in a substantial number of samples. Serum PLP was better in reflecting elevated tHcy and Cys compared to whole blood PLP. Whole blood PLP underestimates the prevalence of vitamin B6 insufficiency. Methods of measuring TPP concentrations in whole blood were exchangeable.
{"title":"Circulating pyridoxal 5′-phosphate in serum and whole blood: implications for assessment of vitamin B6 status","authors":"R. Obeid, Christoph Möller, J. Geisel","doi":"10.1515/labmed-2022-0081","DOIUrl":"https://doi.org/10.1515/labmed-2022-0081","url":null,"abstract":"Abstract Objectives Concentrations of pyridoxal 5′-phosphate (PLP) in serum and whole blood are routinely measured. The suitability of these markers in capturing vitamin B6 insufficiency is not well studied. Methods In 212 subjects, concentrations of PLP and thiamine pyrophosphate (TPP) were simultaneously measured in EDTA-whole blood using Chromsystems® (52052) method on HPLC devices. The whole blood PLP concentrations were compared to serum PLP concentrations measured using reagents from Immundiagnostik® (KC 2100). The whole blood TPP concentrations measured with the Chromsystems® (52052) were compared to those measured by the Chromsystems® (35000) method. Concentrations of homocysteine (tHcy) and cystathionine (Cys) were measured and used to judge the PLP methods. Results Serum PLP concentrations were on average 41% lower than whole blood PLP [mean (SD)=55.4 (83.0) vs. 131 (217) nmol/L]. Serum and whole blood PLP showed a strong correlation [Pearson correlation coefficient=0.724, p<0.001, n=204]. Eighty-five samples showed discrepant results for PLP status (serum PLP ≤30 nmol/L, but whole blood PLP >51 nmol/L) while 102 samples showed coherent results (reference group). The discrepancy group showed higher odds ratio for elevated tHcy >12.0 μmol/L compared to the reference group [OR (95% confidence intervals, CI)=2.1 (1.2–4.0)]. The OR (95% CI) of elevated Cys >300 nmol/L was 1.9 (1.0–3.5) in the discrepancy group compared to the reference group. TPP concentrations were 6% lower when using the Chromsystems®, 52052 compared to levels measured with Chromsystems®, 35000. Conclusions Serum and whole blood PLP concentrations disagree in a substantial number of samples. Serum PLP was better in reflecting elevated tHcy and Cys compared to whole blood PLP. Whole blood PLP underestimates the prevalence of vitamin B6 insufficiency. Methods of measuring TPP concentrations in whole blood were exchangeable.","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"23 - 29"},"PeriodicalIF":1.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45804075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-01DOI: 10.1515/labmed-2022-0108
T. Kıran, O. Otlu, A. Karabulut
Abstract The increase in the formation of reactive oxygen and reactive nitrogen species of endogenous or exogenous origin causes oxidative stress due to pro-oxidant and antioxidant imbalance that causes cellular damage in metabolism. This can increase inflammation of cells, apoptosis and necrosis, damage to DNA base damage, DNA and protein cross-links, lipid membrane peroxidation, and mitochondrial dysfunction. Antioxidants can be described as a system that protects biomolecules and the organism against the harmful effects of free radicals, reduces or repairs the damage done by reactive oxygen species (ROS) to the target molecule, and this is called antioxidant defense. It is known that the mechanisms caused by the increase in ROS resulting from oxidative stress are positively related to the pathology of many diseases such as cancer, metabolic syndrome, atherosclerosis, malaria, Alzheimer’s disease, rheumatoid arthritis, neurodegenerative diseases and preeclampsia.
{"title":"Oxidative stress and antioxidants in health and disease","authors":"T. Kıran, O. Otlu, A. Karabulut","doi":"10.1515/labmed-2022-0108","DOIUrl":"https://doi.org/10.1515/labmed-2022-0108","url":null,"abstract":"Abstract The increase in the formation of reactive oxygen and reactive nitrogen species of endogenous or exogenous origin causes oxidative stress due to pro-oxidant and antioxidant imbalance that causes cellular damage in metabolism. This can increase inflammation of cells, apoptosis and necrosis, damage to DNA base damage, DNA and protein cross-links, lipid membrane peroxidation, and mitochondrial dysfunction. Antioxidants can be described as a system that protects biomolecules and the organism against the harmful effects of free radicals, reduces or repairs the damage done by reactive oxygen species (ROS) to the target molecule, and this is called antioxidant defense. It is known that the mechanisms caused by the increase in ROS resulting from oxidative stress are positively related to the pathology of many diseases such as cancer, metabolic syndrome, atherosclerosis, malaria, Alzheimer’s disease, rheumatoid arthritis, neurodegenerative diseases and preeclampsia.","PeriodicalId":55986,"journal":{"name":"Journal of Laboratory Medicine","volume":"47 1","pages":"1 - 11"},"PeriodicalIF":1.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48013461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：